Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06457906 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

SRS/SRT/Hypo-RT Versus HA-WBRT for No More Than 10 Brain Metastases in SCLC

Study acronym: SHARP
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Interventions: Controled group (HA-WBRT) (Radiation), Experimental group (SRS/SRT/Hypo-RT) (Combination Product) to Controled group (HA-WBRT) (Radiation), Experimental group (SRS/SRT/Hypo-RT) (Combination Product) Eligibility criteria expanded, about 13 words · Study description revised · Publications: details revised at 3 of 3 entries Show 3 more changesShow less
    • Eligibility criteria expanded, about 13 words
    • Study description revised
    • Publications: details revised at 3 of 3 entries
  2. Secondary endpoints: details revised at 2 of 6 entriesv3
  3. Re-verified, no change to tracked fieldsv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This phase III trial compares the effect of stereotactic radiosurgery and whole brain radiation therapy that avoids the hippocampus (the memory zone of the brain) for the treatment of small cell lung cancer that has spread to the brain.
Trial Details
NCT Number NCT06457906
Lead Sponsor Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Conditions Small-cell Lung Cancer, Brain Metastases, SRS, Stereotactic Radiotherapy, Whole Brain Radiotherpay, Hippocampal-avoidance
Enrollment 340 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov